"Risk reduction as a public health strategy to eradicate cigarette smoking", is going to be discussed in Rome on Wednesday 9th November as part of a conference promoted by Motor Health in the "Sala Cristallo" of Hotel Nazionale in Piazza Montecitorio.
prof. Riccardo Polosa, founder of the CoEHAR and one of the leading experts in the field of harm reduction strategies, will speak at the first edition of the congress "Le strade del Respiro", which will be held on Saturday 5 November in Rome.
Among the distinguished speakers, also the expected speech by prof. Riccardo Polosa, founder of CoEHAR.
Harm Reduction strategies were the subject of a speech by prof. Polosa during the National Congress of the Italian Society of Internal Medicine. Focus of this year edition, the management of…
During the 2022 edition of GTNF, the Global Tobacco and Nicotine Forum, Prof. Riccardo Polosa, founder of the CoEHAR, was part of an intense and engaging panel on vaping and tobacco policies at the panel “Banned! Is Prohibition Back?”.
The 5th Scientific Summit on Tobacco Harm Reduction: Novel products, Research & Policy, is organised by SCOHRE, the International Association on Smoking Control & Harm Reduction, and will be held on…
The mapping of Global Research on electronic cigarettes showed that prof. Riccardo Polosa (CoEHAR Center of Excellence for the Acceleration of HArm Reduction, University of Catania) and prof. Maciej L. Goniewicz (Roswell Park Comprehensive Cancer Center, USA) are the most influential authors and the most important researchers in the e-cigarettes research field.
The In Silico Science research team conducted a series of robust and exhaustive systematic reviews to bring forward the best available evidence on the health effects of e-cigarettes on human health developing data for clinicians
The use of e-cigarette among teenagers in the United States is considered a significant public health problem. A close look at federal data now show that the number of young e-cigarette users has markedly declined to below epidemic levels since its peak in 2019.
Quitting smoking can reduce cardiovascular and kidney failure risks. However, it can lead to side effects such as weight gain. A scoping review conducted by a pool of European researchers revealed a lack of data on the metabolic effects of smoking and smoking cessation in diabetes. Healthcare professionals should not assume that cessation of smoking will improve metabolic parameters in patients with diabetes.
We will send you direct emails, without intermediary services, you can withdraw any time.
Copyright 2021 – Center of Excellence for the acceleration of Harm Reduction. All rights reserved.